NCT02183610View on ClinicalTrials.gov

Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2006

Conditions
Healthy
Interventions
DRUG

[14C] BI 1356 as oral (p.o.) solution

DRUG

[14C] BI 1356 solution for i.v. infusion

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY